Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ETFMG Treatments Testing & Adv ETF (NY: GERM )

18.49 +0.09 (+0.49%)
Streaming Delayed Price Updated: 9:49 AM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ETFMG Treatments Testing & Adv ETF

Biotech ETFs That Outperformed Last Week
Though the broad U.S. market saw a tumultuous ride last week with most of the sectors in red, biotechnology was the biggest gainer. 
Via Talk Markets
5 Best Sector ETFs of November
Though the broad markets ended the month in red, a few sector ETFs performed remarkably well. 
Via Talk Markets
Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
After the formidable run, NVAX stock has come under significant pressure, but between its pipeline and its Covid vaccine, it is a dip buy. 
Via InvestorPlace
ETFs to Buy on Most-Bullish Wall Street Outlook in Two Decades
Investors seeking to tap the most bullish view could consider the following ETFs. These funds are showing solid strength this year and will likely continue their momentum going forward. 
Via Talk Markets
Tuesday Talk: Summer Stock
Summer is in full swing and as Q2 ends and its earning season begins it is time to take stock of 1H 2021 and see where things may be heading in 2H. 
Via Talk Markets
Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates
The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to... 
Via Talk Markets
Exposures COVID-19
Moderna Stock Moves After Q1 Print: Technical Levels For The COVID-19 Vaccine Play
Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground. Moderna reported first-quarter earnings Thursday of $2.84 per share, beating the... 
Via Benzinga
Exposures COVID-19
5 Sector ETFs That Crushed The Market In April
Rapid vaccinations, progress on vaccines and expanded stimulus continued to drive stocks higher; the USA is expected to become the engine of the global economy this year. Here, 5 ETFs that should... 
Via Talk Markets
Topics Economy
Exposures Economy
5 Niche ETFs Dominating the Current Market Rally
Wall Street has been enjoying continued ascent with the S&P 500 and Dow Jones hitting a series of record highs. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.